Skip to main content
Clinical Trials/NL-OMON55610
NL-OMON55610
Completed
Not Applicable

Symptom perception in patients with functional dyspepsia: involvement of the TRPV-1 neuropeptide pathway - Functional dyspepsia and symptom perception

Medisch Universitair Ziekenhuis Maastricht0 sites70 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Functional dyspepsia
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
70
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • Healthy controls \<\= No gastrointestinal symptoms or history of gastrointestinal
  • disease, especially not meeting criteria for functional dyspepsia and IBS
  • (according to the ROME III criteria), Functional dyspepsia patients \<\= Patients
  • referred for upper gastrointestinal endoscopy by either general practitioners
  • or doctors from the gastroenterology outpatient clinic, meeting ROME III
  • criteria for functional dyspepsia

Exclusion Criteria

  • Healthy volunteers and functional dyspepsia patients:
  • 1\. Inability to stop the intake of NSAIDs within 14 days prior to endoscopy.
  • 2\. Inability to stop the intake of medication affecting gastrointestinal
  • function (e.g. proton pump inhibitors, prokinetics, laxatives) within 5 days
  • prior to endoscopy
  • 3\. Current use of antidepressants
  • 4\. Medical history of diabetes mellitus
  • 5\. Medical history of coeliac disease
  • 6\. Organic disease at upper gastrointestinal endoscopy (i.e. erosive
  • esophagitis, Barrett\*s esophagus, benign esophageal stricture, Schatzki ring,

Outcomes

Primary Outcomes

Not specified

Similar Trials